Bigul

Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On March 31, 2017.

In compliance with the provisions of Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are forwarding herewith the Certificate of Mr. Manoj Hurkat, Practicing Company Secretary for the Half Year ended on March 31, 2017 received on April 13, 2017
13-04-2017
Bigul

Updates

As required under regulation 33(3)(c)(ii) of SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we hereby inform that the Company will publish audited financial results for the F.Y. 2016-17 within 60 days of the end of financial year i.e. by May 30, 2017.
10-04-2017
Bigul

Statement Of Investor Complaints As On March 31, 2017.

In compliance with the provisions of Regulation 13 (3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, the status of Investor Complaints as on March 31, 2017 is as under: Sr. No.ParticularsStatus of Complaints 1.Complaints pending at the beginning of the QuarterNIL 2.Complaints received during the Quarter6 3.Complaints disposed of during the Quarter6 4.Complaints remaining unresolved at the end of the QuarterNIL
10-04-2017
Bigul

Shareholding for the Period Ended March 31, 2017

Cadila Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here
10-04-2017
Bigul

Cadila Healthcare says Changodar plant has got no USFDA observation

The plant was inspected by the US FDA between April 3 and April 7
08-04-2017
Bigul

Updates

Cadila's Topical manufacturing facility successfully completes USFDA inspection.
07-04-2017
Bigul

Compliance Certificate Under Regulation 7(3) Of LODR - 2015 For The Half Year Ended March 31, 2017

We hereby certify that all activities in relation to both physical and electronic share transfer facilities are maintained by our Registrar and Share Transfer Agent i.e. Link Intime India Private Limited [Link Intime] having its branch at 5th Floor, 506 TO 508, Amarnath Business Centre 1 ( ABC-1), Beside Gala Business Centre, Nr. St. Xavier's College Corner, Off C G Road, Navrangpura, Ahmedabad - 380009. Further, we confirm that Link Intime is...
06-04-2017

Cadila gets shareholders' nod for scheme of arrangement with Zydus Healthcare

Almost 100% shareholders have approved the scheme of arrangement between Cadila Healthcare and Zydus Healthcare
01-04-2017
Bigul

Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Cadila Healthcare Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-04-2017
Bigul

Voting Results Of The Meeting Of Equity Shareholders Of The Company Held On March 30, 2017 Pursuant To The Final Order Passed By The National Company Law Tribunal [NCLT

Please find enclosed the voting results of the NCLT convened meeting of the Equity Shareholders of the Company held on March 30, 2017 at J B Auditorium, Ahmedabad Management Association, ATIRA Campus, Dr. Vikram Sarabhai Marg, Ahmedabad - 380015
01-04-2017
Next Page
Close

Let's Open Free Demat Account